This announcement is a separate document:
江苏康缘药业股份有限公司关于回购注销公司2022年度限制性股票激励计划部分已授予但尚未解除限售的限制性股票的公告
Announcement of Jiangsu Kangyuan Pharmaceutical Co., Ltd. on the repurchase and cancellation of restricted shares granted in part of the 2022 restricted stock incentive plan of the company but the sales restrictions have not yet been lifted
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.